Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma.

Name: Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma.
Author: Feng, Wenqin

Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma. — المؤلف: Feng, Wenqin — Cancer cell international May 2022

المؤلف: Feng, Wenqin
النشر: Cancer cell international May 2022
الوصف: 186 p.